Yahoo Web Search

  1. Who Has Been Selling Pfizer Inc. (NYSE:PFE) Shares?

    Simply Wall St. via Yahoo FinanceApr 10 11:13 AM

    So before you buy or sell Pfizer Inc. (NYSE:PFE), you may well want to know whether insiders have been buying or selling. It's quite normal to see company insiders, such as board members, trading in company stock, from time to time.

  2. Pfizer (PFE) closed the most recent trading day at $42.73, moving -0.26% from the previous trading session. This move lagged the S&P 500's daily gain of 0.35%. Heading into today, shares ...

  3. Pfizer, Inc. s PFE blockbuster medicine Ibrance gained FDA approval for the treatment of breast cancer in men, thereby expanding the drug's eligible patient population. Ibrance ...

  4. Alector Inc (NASDAQ: ALEC) Denali Therapeutics Inc (NASDAQ: DNLI) GENFIT S A/ADR (NASDAQ: GNFT) Ionis Pharmaceuticals Inc (NASDAQ: IONS) Moderna Inc (NASDAQ: MRNA ...

  5. The index traversed a lackluster trading week as investors looked toward first-quarter earnings numbers for direction. The latest Fed minutes reaffirmed its recent dovish stance, providing some ...

  6. Stocks recently featured in the blog include: Pfizer PFE, Teva TEVA, Novartis NVS, Merck MRK and AstraZeneca AZN. This week Pfizer and Teva gained marketing approval from the European ...

  7. We expect Pfizer, Inc. PFE to beat estimates when it reports first-quarter 2019 results on Apr 30, before market open. In the last reported quarter, the company delivered a positive ...

  8. This week Pfizer PFE and Teva TEVA gained marketing approval from the European Commission for their new medicines. While Pfizer gained approval for its new lung cancer medicine ...

  9. On Apr 5, we issued an updated research report on Corcept Therapeutics Incorporated CORT. Corcept’s only marketed drug, Korlym, is approved for the once-daily oral treatment of hyperglycemia ...

  10. Can Q1 Earnings Lift Healthcare ETFs Higher?

    Zacks via Yahoo FinanceApr 18 14:59 PM

    Price, Consensus and EPS Surprise Pfizer Inc. Price, Consensus and EPS Surprise | Pfizer Inc. Quote Merck is expected to report results on Apr 30 before market open.

  1. Ads
    related to Pfizer, Inc